Étiquette : Dermatology

PORSOLT

by jbertholdin Institutions, Service Providers & others

PORSOLT

About the company

Porsolt, a long established, AAALAC accredited and fully GLP compliant, preclinical CRO, has been providing efficacy evaluation and safety pharmacology services for over 40 years, covering the drug development process from early screening through regulatory submission.

About the solution

Porsolt provides discovery and preclinical services (safety & efficacy) including in vitro assays, pathophysiological models in multiple species and cell lines, customized procedures, and tailored solutions. They offer to support drug development using high throughput screening, high content analysis, and high content histology platforms, drug formulation analysis, and bioanalytical services.

Their vast expertise covers the following areas: psychiatric and neurological disorders, cardiac and vascular diseases, oncology, pain, inflammation, gastrointestinal disorders, liver diseases, metabolic and eating disorders, respiratory diseases, dermatology, medical devices, and predictive toxicity of compounds.

Website
Key information

–  Therapeutic areas: Cardiovascular System, Central Nervious System,Dermatology,Gastrointestinal System,Histoilogy, Inflammation, Liver & Hepatic System,Medical Devices,Obesity & Metabolic Disorders, Oncology,Pain, Pharmacokinetics, Predictive Toxicity, Respiratory System, Safety Regulatory Package, Thrombosis/ Blood, Urogenital System,Biomarkers Assays, Cell & Tissue Banks,Formulation Analysis, Image Processing & Data Analysis,Technical Skills,Technical Capabilities.

–  Based in: Le Genest Saint Isle (FRANCE)

–  Employees: 51 – 200

–  Created in: 1940

ERBC GROUP

by jbertholdin Institutions, Service Providers & others

ERBC GROUP

About the company

ERBC group is a leader in discovery and non-clinical studies, offering to healthcare and chemical professionals a comprehensive range of discovery and preclinical models, regulatory pre-IND package and consultancy services to de-risk innovation and improve R&D productivity.

About the solution

At ERBC Group, THEY STRATEGIZE your approach to make your drug development a SUCCESS:
– Build on most relevant translational models
– Select best predictive biomarkers
– Choose state-of-the-art technologies.

Website
Key information

–  Therapeutic areas: Oncology – Cancer, Immunology, Inflammation, Neurology – Neurosciences, Cell and gene therapies, Cardiovascular, Infectious diseases, Metabolic diseases – Hepatology – Diabetes, Gastroenterology, Respiratory, Ophthalmology, Allergy, Dermatology, Orthopedics, Central nervous system, Nephrology, Cardiology, Pulmonology, Endocrinology, Hematology

–  Based in: Baugy, Toulouse, Lyon, Orleans (FRANCE)

–  Employees: 201-500

–  Created in: 2019

AMKBIOTECH

by jbertholdin Biotech, Digital Health, Pharma

AMKBIOTECH

About the company

AMKbiotech is an innovative service laboratory proving highplex tissue imaging solutions for biomarker identification and target efficacy validation.

About the solution

AMKbiotech combines the development of a novel tissue processing and imaging approach with AI-based analytical tools to generate 200 times more data from a single tissue section, while saving 80% of the resources needed for such analysis with classical histology approaches, in a 2 times faster execution period.

Website
Key information

–  Therapeutic areas: Histopathology, Oncology, Dermatology, Inflammatory disease

–  Based in: Sophia-Antipolis (FRANCE)

–  Employees: 1-10

–  Created in: 2021

INOVARION

by jbertholdin Institutions, Service Providers & others

INOVARION

About the company

Inovarion is a Life Sciences company based in Paris offering preclinical and fundamental research services.

Since 2013, Inovarion provides support to the pharmaceutical, biotechnology industries and academics in the form of research services outsourced on a contract basis. They help biotech companies to reach clinical trials faster outsourcing their R&D to Inovarion in France.

They have been working as an extension of their partners’ teams for Sanofi, L’Oréal, Inserm (French NIH), Gustave Roussy, and many more.

About the solution

Inovarion has developed a strong expertise in bioinformatics, oncology, immunology and molecular biology.
They are well established in the research landscape in France and published +140 scientific papers in the highest ranked reviews (Nature, Science, The Lancet, Cell…).

Here are their main advantages:
⁃ Scientific French excellence
⁃ Cost effectiveness thanks to French tax credits : 25%-40% less vs US project cost
⁃ Talent loyalty & stability: less than 5% staff turnover per year in our team

Their goal is to build up close and long-term cooperation with pharmaceutical and biotechnologiy companies worldwide, to offer them in France, very attractive conditions, both financial and time-saving, for conducting top-notch fundamental and preclinical research and beyond that, to achieve together scientifical victories in medicine.

Website
Key information

–  Therapeutic areas: Immuno-oncology, Neuroscience, Dermatology, Oncology, Immunology

–  Based in: Paris (FRANCE)

–  Employees: 51-200

–  Created in: 2013

ETAP-LAB

by jbertholdin Institutions, Service Providers & others

ETAP-LAB

About the company

ETAP-Lab is a preclinical CRO renowned for its expertise in the fields of dermatology, neurology, cardiology and gastroenterology. It assesses the effectiveness of drug candidates and medical devices.

Founded in 1991, ETAP-Lab has now worked with 150 companies ranging from small biotechs to large pharmaceutical groups, both in France and further afield. Ever since the company’s earliest days, ETAP-Lab models have consistently offered high translational value associated with relevant protocols. Mainly comprised of scientific experts, our team analyses client requirements, offering guidance and advice in the development of a tailor-made solution.

ETAP-Lab studies are conducted to exacting quality standards, ensuring the reproducibility, transparency and traceability of tests while maintaining responsiveness and offering regular dialogue with our project managers.

About the solution

ETAP-Lab can fast-track your pipeline with preclinical excellence having high predictability level through in vitro and in vivo testing and rodent behavioural analysis:

– DERMATOLOGY: Wide portfolio of original inflammatory (psoriasis, atopic dermatitis) and wound-healing in vivo models.

– CARDIOLOGY: In-depth in vivo studies of major cardiovascular diseases like Pulmonary Arterial Hypertension, Ischemia Reperfusion, and Heart failures.

– NEUROLOGY: Original and translational in vivo and in vitro models of Stroke and neurodegenerative diseases like Alzheimer’s and Parkinson’s models.

– GASTROENTEROLOGY: In vivo models of gastrointestinal disorders like irritable bowel syndrome (IBS) and traveler’s diarrhea. Expertise in metabolic disturbances such as diabetes, obesity, and malnutrition.

Website
Key information

– Therapeutic areas: Dermatology, Neurology, Cardiology, Gastroenterology, Metabolism

– Based in: Production sites in France

– Employees: 11 – 50

– Created in: 1991

CLINSEARCH

by jbertholdin Institutions, Service Providers & others

CLINSEARCH

About the company

ClinSearch is a full service European CRO, established in 1999, offering clinical research and medical evaluation services throughout Europe, as well as the Middle East and the United States.

They have conducted hundreds of studies, from phase I to IV studies, early access programs, post-marketing studies, RWE, PASS, PAES, database analyses and medico-economic studies, involving 1 patient up to 220,000 subjects.
Their customers include global and local medical device, biotechnology and pharmaceutical companies, as well as public health institutions.

About the solution

Full service offering from A to Z: methodological input to study design through to peer-reviewed publications, passing via in-house development of sophisticated healthcare tools (EDC, ePRO, …).

The in-house team of over 70 people work from our headquarters in Malakoff (France), but hail from ~15 different countries and speak over 10 languages, and are trained to a high standard (MD, PhD, PharmD, MS, MPH …).

Website
Key information

–  Therapeutic areas: Addiction, Aesthetics, Algorithm, Software, Cardiovascular, Dermatology, Fertility, Immunology, Infectiology, Hematology, Neurology, Neuromuscular, Neurovascular, Nursing care, Orthopedic, Oncology, Rheumatology, Rare diseases, Respiratory, Surgery, Urology

–  Based in: Boston (USA)

–  Employees: 51-200

–  Created in: 1999

SYNCROSOME

by jbertholdin Institutions, Service Providers & others, Pharma

SYNCROSOME

About the company

SYNCROSOME is a CRO specialized in vivo efficacy studies with high expertise in cardiovascular, CNS, dermatology gastroenterology, metabolic disorders as well as respiratory fields for 23 years.

About the solution

They rely on a high expertise in animal models, high reactivity and high content data evaluation.

Website
Key information

–  Therapeutic areas: CNS, Cardiology, Gastrology, Dermatology, Respiratory and Metabolic disorders

–  Based in: Marseille (FRANCE)

–  Employees: 1 – 10

–  Created in: 2000

HTL BIOTECHNOLOGY

by jbertholdin Biotech, Pharma

HTL BIOTECHNOLOGY

About the company

HTL Biotechnology is a French biotech company and world leader in the development and responsible bioproduction of pharmaceutical-grade biopolymers. These biopolymers are used by healthcare companies for the development of treatments in a wide range of leading therapeutic areas such as ophthalmology, dermatology, medical aesthetics, and rheumatology.

For over 30 years, HTL Biotechnology has been a driving force for innovation in the sector, collaborating with research entities and biotech companies to address tomorrow’s medical needs (regenerative medicine, drug delivery, etc.). HTL Biotechnology is a fast-growing international company, exporting nearly 80% of its production to over 30 countries. To meet these growing global needs for biopolymers, HTL Biotechnology has also established subsidiaries in Singapore and the United States, including the construction of a production unit for a neuromodulator. Historically based in Javené (Brittany), the company consolidates production, innovation, research and development, and quality activities on-site. HTL Biotechnology employs nearly 300 collaborators worldwide.

About the solution

Biopolymers are at the heart of today’s and tomorrow’s therapeutic innovations, HTL Biotechnology offers:

Today’s portfolio: pharmaceutical-grade hyaluronic acid, PN & PDRN, cosmetic-grade sodium DNA

Quality is essential, and HTL guarantees that all its products comply with the highest quality standards and good manufacturing practices (GMP-compliant). Our commitment to safety and excellence is proven: no batch recalls in three decades, auditing and certification by regulatory bodies such as the FDA (USA). – Innovation portfolio: heparosan, oligo-HA – Biopolymer platform service: HTL offers expert advice and support to companies wishing to embark on the industrial production of a modified hyaluronic acid compound.

Website
Key information

–  Therapeutic areas: Ophthalmology, Dermatology, Medical Aesthetics, Rheumatology

–  Based in: Javené (FRANCE) Subsidiary : HTL BMI based in Massachusetts (US)

–  Employees: 201 – 500

– Created in: 1992

QIMA LIFE SCIENCES

by jbertholdin Institutions, Service Providers & others

QIMA LIFE SCIENCES

About the company

QIMA Life Sciences brings together QIMA Bioalternatives, Newtone Technologies, and Monasterium Laboratory. The companies provide innovative testing and research solutions ranging from in silico screening to clinical imaging, as well as in vitro and ex vivo assays and non-invasive clinical sample bioanalysis. They also offer the exclusive “Blood assay solutions” for fresh whole blood testing.

They contribute to the development of testing methods as an alternative to animal experimentation, by offering solutions dedicated to preclinical research and to the development of drug candidates and to cosmetic active ingredients and formulations.

About the solution

The company provides a 360° offer with innovative testing and research solutions ranging from in silico screening to clinical imaging, as well as in vitro and ex vivo assays and non-invasive clinical sample bioanalysis.

Website
Key information

–  Therapeutic areas: Dermatology, Oncology, immunology, Neurobiology

–  Based in: Gençay (FRANCE)

–  Employees: 51 – 200

– Created in: 1996

ATLANTIC BONE SCREEN

by jbertholdin Biotech, Pharma

ATLANTIC BONE SCREEN

About the company

Atlantic Bone Screen is a French CRO providing non-GLP preclinical services.
Atlantic Bone Screen has a strong know-how in the field of osteoarticular indications / bone and joint diseases / biomaterials : inflammation & oncology & dermatology.
Atlantic Bone Screen has developed in vitro tests, in vivo animal models and benefits from robust and state-of-the-art platforms for 2D and 3D imaging, histology and histopathology.
Atlantic Bone Screen supports biotech and pharma companies to identify and characterize the therapeutic potential of their drug candidates, nutraceuticals and biomaterials through validated models and customized preclinical studies.

About the solution

Their specific expertise in bone physiology and bone diseases, cartilage and inflammatory diseases, and cancer models sets them apart from other global CROs.

Based on their internal experts and scientific network, they address their customers’ questions regarding their candidates and support them in screening, characterization, and validation of their leads to generate strong data for advancing through regulatory stages.

Additionally, their flexibility in customizing study designs, readouts, and communication and providing comprehensive reports throughout projects is highlighted as a real strength by their partners (96% of customers were either satisfied or very satisfied in the 2023 satisfaction survey).

Website
Key information

–  Therapeutic areas: Oncology, Bone Diseases, Osteoarticular Diseases, Inflammation, Dermatology, Cosmetics, Biomaterials.

–  Based in: Nantes

–  Employees: 11 – 50

– Created in: 2005